| -Change in Other Current Liabilities |
-$993,000.00 |
-$2.48M |
-$12.59M |
-$879,000.00 |
-$2.81M |
| -Change In Other Working Capital |
$1.36M |
$14.37M |
-$13.77M |
-$5.24M |
-$6.04M |
| -Change in Payables and Accrued Expense |
$1.94M |
$47.45M |
-$8.73M |
-$60.52M |
$39.05M |
| -Change in Inventory |
-$5.07M |
$12.16M |
$35.77M |
-$36.32M |
-$2.60M |
| -Change in Receivables |
$184.53M |
$11.73M |
-$64.60M |
-$253.03M |
$138.24M |
| Change in Working Capital |
$181.77M |
$83.22M |
-$63.91M |
-$355.99M |
$165.85M |
| Other Non-Cash Items |
$9.58M |
$13.44M |
$5.13M |
-$899,000.00 |
$1.14M |
| Deferred Tax |
-$5.63M |
-$8.83M |
$4.98M |
$49.47M |
-$23.44M |
| Depreciation & Depletion & Amortization |
$33.78M |
$32.60M |
$30.95M |
$29.23M |
$30.20M |
| Net Income from Continuing Operations |
$81.39M |
$88.53M |
$99.48M |
$68.80M |
$51.32M |
| Net cash flow from continuing operations |
$316.85M |
$220.91M |
$91.84M |
-$195.78M |
$298.32M |
| Operating Cash Flow |
$316.85M |
$220.91M |
$91.84M |
-$195.78M |
$298.32M |
| Free Cash Flow |
$294.22M |
$202.36M |
$75.87M |
-$217.48M |
$283.72M |
| Net cash flow from investing |
-$60.52M |
-$84.64M |
-$9.95M |
-$24.72M |
-$34.65M |
| Net Cash Flow from Continuing Investing Activities |
-$60.52M |
-$84.64M |
-$9.95M |
-$24.72M |
-$34.65M |
| Beginning Cash Balance |
$614.05M |
$497.10M |
$518.44M |
$782.50M |
$531.13M |
| Net Change in Cash |
$140.45M |
$116.95M |
-$21.34M |
-$264.06M |
$251.36M |
| Ending Cash Balance |
$754.50M |
$614.05M |
$497.10M |
$518.44M |
$782.50M |
| Proceeds from Stock Option Exercised |
-$289,000.00 |
-$3.98M |
-$604,000.00 |
-$31.59M |
-$797,000.00 |
| Net Common Stock Issuance |
-$100.01M |
$0.00 |
– |
– |
$0.00 |
| Net Issuance Payments Of Debt |
-$15.58M |
-$15.34M |
-$13.98M |
-$11.96M |
-$11.51M |
| Net Cash Flow from Continuing Financing Activities |
-$115.88M |
-$19.32M |
-$103.23M |
-$43.56M |
-$12.31M |
| Financing Cash Flow |
-$115.88M |
-$19.32M |
-$103.23M |
-$43.56M |
-$12.31M |
| Net Other Investing Changes |
-$1.20M |
-$4.05M |
-$47.72M |
-$2.57M |
-$19.00M |
| Net Investment Purchase and Sale |
-$36.69M |
-$62.05M |
$53.74M |
-$453,000.00 |
-$1.05M |
| Net PPE Purchase and Sale |
$0.00 |
-$535,000.00 |
$254,000.00 |
-$306,000.00 |
-$431,000.00 |
| Capital Expenditure |
-$22.63M |
-$18.01M |
-$16.23M |
-$21.39M |
-$14.17M |
No comments yet — be the first to weigh in on LRN.